Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples